Clinical Trial Update: Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY [Phase 1]

View source ↗

Summary

The PREV-NOSE Phase 1 trial evaluating Nozin to prevent respiratory viral infections in patients undergoing stem cell transplant was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Nozin

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Status: TERMINATED